Silvercrest Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,099
Closed -$771K 869
2025
Q3
$771K Buy
14,099
+4,261
+43% +$213K 0.01% 646
2025
Q2
$523K Buy
9,838
+300
+3% +$15.2K ﹤0.01% 708
2025
Q1
$413K Buy
9,538
+1,546
+19% +$78.3K ﹤0.01% 734
2024
Q4
$449K Buy
7,992
+641
+9% +$39.9K ﹤0.01% 709
2024
Q3
$501K Sell
7,351
-2,451
-25% -$138K ﹤0.01% 650
2024
Q2
$414K Buy
9,802
+3,275
+50% +$180K ﹤0.01% 752
2024
Q1
$451K Buy
6,527
+72
+1% +$4.55K ﹤0.01% 725
2023
Q4
$478K Sell
6,455
-114
-2% -$7.47K ﹤0.01% 675
2023
Q3
$448K Buy
6,569
+212
+3% +$18K ﹤0.01% 691
2023
Q2
$597K Buy
6,357
+1,875
+42% +$146K ﹤0.01% 659
2023
Q1
$304K Buy
+4,482
New +$288K ﹤0.01% 718
2022
Q2
Sell
-4,250
Closed -$297K 823
2022
Q1
$297K Buy
4,250
+231
+6% +$16.9K ﹤0.01% 764
2021
Q4
$313K Buy
4,019
+228
+6% +$20.1K ﹤0.01% 734
2021
Q3
$362K Sell
3,791
-97
-2% -$10.2K ﹤0.01% 728
2021
Q2
$483K Sell
3,888
-439
-10% -$52.4K ﹤0.01% 678
2021
Q1
$570K Buy
4,327
+458
+12% +$62.7K ﹤0.01% 641
2020
Q4
$513K Buy
3,869
+843
+28% +$102K ﹤0.01% 628
2020
Q3
$309K Buy
+3,026
New +$261K ﹤0.01% 670

Other funds holding EXAS

Silvercrest Asset Management's EXAS Position: Q4 2025 in Review

Silvercrest Asset Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 14,099 shares — an estimated $771K sold.

Silvercrest Asset Management first reported a position in EXAS in Q3 2020 and held it in 18 quarters. The position peaked at $771K in Q3 2025. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Silvercrest Asset Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Silvercrest Asset Management sold 14,099 Exact Sciences shares in Q4 2025, an estimated $771K.
  • Silvercrest Asset Management first reported a position in Exact Sciences in Q3 2020 and held it in 18 quarters.
  • Silvercrest Asset Management's Exact Sciences position peaked at $771K in Q3 2025.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Silvercrest Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.